Caladrius Biosciences, Inc.
(NASDAQ : CLBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Wholesale Distributors
symbolcompany%chnglast%shortavg$volume
GWWW.W. Grainger, Inc.
0.32%307.7711.8%$252.30m
FASTFastenal Company
-0.21%52.766.9%$127.88m
GPCGenuine Parts Company
-0.32%92.371.8%$105.37m
HDSHD Supply Holdings, Inc.
-0.27%40.611.7%$53.54m
POOLPool Corporation
0.30%148.842.1%$43.15m
BECNBeacon Roofing Supply, Inc.
1.11%40.272.4%$41.40m
MSMMSC Industrial Direct Co., Inc. Class A
-0.52%94.314.1%$36.71m
WCCWESCO International, Inc.
0.51%59.352.9%$31.97m
UNVRUnivar, Inc.
0.47%28.091.3%$28.00m
DNOWNOW Inc
2.08%15.226.1%$26.02m
INTWorld Fuel Services Corporation
-1.30%22.063.6%$22.29m
AITApplied Industrial Technologies, Inc.
0.42%71.401.2%$18.54m
MRCMRC Global Inc.
0.73%20.815.3%$15.20m
ESNDEssendant Inc.
4.73%13.722.4%$10.81m
SUNSunoco LP
-0.04%26.864.2%$10.54m

Company Profile

Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. The company was founded in September 1980 and is headquartered in New York, NY.